Matches 251 - 297 out of 297 < 1 2 3 4 5 6


Match Document Document Title
US20100255102 STERILIZATION OF DISPERSIONS OF NANOPARTICULATE ACTIVE AGENTS WITH GAMMA RADIATION  
The present invention relates to methods for sterilization of dispersions of one or more nanoparticulate active agents via gamma irradiation.
US20100226990 Method of Producing Porous Microparticles  
A method of preparing porous microparticles comprises the steps of combining one or more organic compounds with a volatile system, and drying the system thus formed to provide substantially pure...
US20110262543 PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES  
Carrier particles for dry powder formulations for inhalation having reduced electrostatic charges are prepared.
US20170143742 BERBERINE-URSODEOXYCHOLIC ACID CONJUGATE FOR TREATING THE LIVER  
The present invention is a method and compound for treating specific cancerous cell lines. The invention treats liver cancer by directing a cancer-fighting drug into the liver hepatoportal...
US20170100411 CORTICOSTEROID FORMULATIONS FOR MAINTAINING CORTICOSTEROID SYNOVIAL FLUID CONCENTRATIONS  
This invention relates to compositions and methods for achieving and maintaining maximal analgesic effect following intra-articular administration of corticosteroid formulations. The invention...
US20170079988 CICLESONIDE FOR THE TREATMENT OF AIRWAY DISEASE IN HORSES  
The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to glucocorticoids, especially ciclesonide or a pharmaceutically acceptable...
US20170071855 ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS  
The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the...
US20160361325 TOPICAL FORMULATIONS COMPRISING A STEROID  
The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are propellant-free, and/or...
US20160235767 TOPICAL FORMULATIONS COMPRISING A STEROID  
The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are propellant-free, and/or...
US20160199391 BERBERINE-URSODEOXYCHOLIC ACID CONJUGATE FOR TREATING THE LIVER  
The present invention is a method and compound for treating specific cancerous cell lines. The invention treats liver cancer by directing a cancer-fighting drug into the liver hepatoportal...
US20160193342 Modified Hyaluronic Acid Polymer Compositions and Related Methods  
The present application provides compositions comprising hyaluronic acid having low levels of functional group modification, mixtures formed by controlled reaction of such lightly modified...
US20160185815 BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF  
The present invention provides compounds of Formula I, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated...
US20160176917 Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof  
The present invention provides compounds of Formula I, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated...
US20160166508 Method and Composition for Treating Inflammatory Disorders  
There is provided homogeneous pharmaceutical compositions for the treatment of inflammatory disorders comprising an antiinflammatory and/or antihistaminic active ingredient, a polar lipid liposome...
US20160158384 SULFOALKYL ETHER CYCLODEXTRIN COMPOSITIONS  
SAE-CD compositions are provided, along with methods of making and using the same. The SAE-CD compositions comprise a sulfoalkyl ether cyclodextrin having an absorption of less than 0.5 A.U. due...
US20160158146 OCULAR THERAPEUTIC AGENT DELIVERY DEVICES AND METHODS FOR MAKING AND USING SUCH DEVICES  
Ocular implant devices (10, 20, 121) for the delivery of a therapeutic agent to an eye (101, 301) in a controlled and sustained manner. Dual mode and single mode drug delivery devices (10, 20,...
US20160151393 PULMONARY PHARMACEUTICAL FORMULATIONS  
The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as...
US20160130297 BILE ACID ANALOGS AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF  
The present invention relates to compounds of Formula (I), and pharmaceutically acceptable salts thereof, where R1, R2, R3, R4, R5, R6, R7, R8 and m are as defined herein, pharmaceutical...
US20160084846 METHODS AND COMPOSITIONS FOR DETERMINING RELAPSE IN INFLAMMATORY BOWEL DISEASE  
Described are methods and compositions for evaluating the relapse risk n subjects having an inflammatory bowel disease (IBD). Some embodiments include selecting a treatment for an evaluated IBD...
US20160074321 OPHTHALMIC COMPOSITION, METHOD FOR PREPARING THE SAME, AND USE OF THE SAME  
The present invention is directed to an ophthalmic composition, method for preparing the same, and use of the same. The ophthalmic composition includes a mixture of lipid nano-dispersion and gel...
US20160069907 RGMa Fragment Based Diagnostic Assay  
Provided are diagnostic assays and method s of using the diagnostic assays for detecting and quantifying RGMa fragments in a sample. The methods may be used detection of the RGMa fragments to...
US20160058669 TOPICAL PHARMACEUTICAL COMPOUNDS AND METHODS  
Methods to enable a visual check on the mixing proper pharmaceutical compounding kits. The methods include providing a kit with a colored inactive to be added to the mixture. When the mixture is...
US20160051683 EXCIPIENT COMPOSITIONS FOR MUCOADHESIVE PHARMACEUTICAL COMPOSITIONS INCLUDING A SYNERGISTIC COMBINATION OF AMYLOPECTIN, PULLULAN, HYALURONIC ACID, AND XYLOGLUCAN  
Excipient compositions including a combination of excipients for mucoadhesive pharmaceutical compositions that improve mucoadhesiveness power, as well as release of and adhesion time of suitable...
US20160051568 CYCLODEXTRIN AND BUDESONIDE DERIVATIVE COMPOSITIONS AND METHODS  
The present invention relates to novel and useful pharmaceutical compositions formulated with a cyclodextrin compound and a budesonide derivative for the treatment and/or prevention of pulmonary...
US20160045518 VISCOUS BUDESONIDE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT  
Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those...
US20160045434 COMPOSITION COMPRISING AT LEAST TWO DRY POWDERS OBTAINED BY SPRAY DRYING TO INCREASE THE STABILITY OF THE FORMULATION  
The present invention relates to inhalation formulations of drugs in the form of dry powder for inhalation administration deliverable as such with an inhaler and provided with high deliverability,...
US20160022704 Fluocinolone Formulations in a Biodegradable Polymer Carrier  
Effective treatments of pain and inflammation are provided. Through the administration of an effective amount of fluocinolone at or near a target site, one can reduce, prevent or treat...
US20160015634 AQUEOUS SUSPENSIONS OF CICLESONIDE FOR NEBULISATION  
This invention relates to a method for the preparation of sterile aqueous suspensions of ciclesonide by sterilization with moist heat. The invention further relates to pharmaceutical compositions...
US20160000709 DRY POWDER INHALER FORMULATIONS COMPRISING SURFACE-MODIFIED PARTICLES WITH ANTI-ADHERENT ADDITIVES  
The present invention is concerned with a refinement of the processing of particles that are to form a dry powder formulation which is to be administered to the lung using a dry powder inhaler...
US20150377903 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BIOMARKERS AND USES THEREOF  
Methods, compositions, and kits for predicting whether a subject with chronic obstructive pulmonary disease (COPD) or at risk of developing COPD is likely to have progressive COPD are provided....
US20150376225 NOVEL COMPOUNDS OF 11BETA-HYDROXY-STEROIDS FOR USE IN MITOCHONDRIA BIOGENESIS AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION OR DEPLETION  
The present invention provides novel compounds of 11β-hydroxy steroids and compositions and their application as pharmaceuticals for preventing or reversing injury to mitochondria, for treating or...
US20150352128 CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITION  
Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic,...
US20150337006 PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF  
The present invention further provides method of preparing nanocrystals or microcrystals of a hydrophobic therapeutic agent such as fluticasone or triamcinolone, pharmaceutical compositions (e.g.,...
US20150335704 PHARMACEUTICAL COMPOSITIONS COMPRISING GELS AND METHODS FOR FABRICATING THEREOF  
Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel. Methods for fabricating the...
US20150335572 Medicated Hard Candy Product For Treating Esophageal Inflammation And A Method Using The Same  
A medicated hard candy product for treating eosinophilic esophagitis (EoE) is disclosed herein. The medicated hard candy product includes a hard candy base material, the hard candy base material...
US20150313918 CICLESONIDE FOR THE TREATMENT OF AIRWAY DISEASE IN HORSES  
The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to glucocorticoids, especially ciclesonide or a pharmaceutically acceptable...
US20150290220 Pharmaceutical formualtions comprising a Gluococorticosteroid  
Sterile formulation comprising glucocorticosteroids, process for the preparation of the sterile formulation and method of using the same are provided. The present invention also relates to sterile...
US20150274638 COMPLEX AND STRUCTURALLY DIVERSE COMPOUNDS  
The invention provides a novel, general, and facile strategy for the creation of small molecules with high structural and stereochemical complexity. Aspects of the methods include ring system...
US20150272965 Porous Silicon Drug-Eluting Particles  
The invention provides a biodegradable drug-eluting particle useful for the delivery of diagnostic or therapeutic agents. In certain embodiments, the drug-eluting particle of the invention...
US20150265542 NANOCRYSTALS, COMPOSITIONS, AND METHODS THAT AID PARTICLE TRANSPORT IN MUCUS  
Nanocrystals, compositions, and methods that aid particle transport in mucus are provided. In some embodiments, the compositions and methods involve making mucus-penetrating particles (MPP)...
US20150265531 AEROSOL COMPOSITION FOR ADMINISTERING DRUGS  
Described here are compositions and methods for the treatment of respiratory conditions using glucocorticosteroids delivered by a next generation nebulizer. The methods administer a therapeutic...
US20150071988 Sterically Stabilized Carrier For Aerosol Therapeutics, Compositions And Methods For Treating The Respiratory Tract Of A Mammal  
This invention comprises a sterically stabilized liposome carrier encapsulating a selected drug for the aerosol delivery of the drug effectual in the treatment of a mammal, a composition...
US20140147506 Delivery of Submicrometer and Nanometer Aerosols to the Lungs using Hygroscopic Excipients or Dual Stream Nasal Delivery  
Pharmaceutically engineered aerosols (e.g. submicrometer and nano-particles and droplets) containing a hygroscopic growth excipient or agent are employed to improve the delivery of respiratory...
US20130101646 Method of Producing Microparticles  
A method of producing microparticles having a median diameter up to 100 μm and the microparticles so produced are described. The method includes the steps of providing a solvent having a bioactive...
US20120251594 Delivery of Submicrometer and Nanometer Aerosols to the Lungs Using Hygroscopic Excipients or Dual Stream Nasal Delivery  
Pharmaceutically engineered aerosols (e.g. submicrometer and nano-particles and droplets) containing a hygroscopic growth excipient or agent are employed to improve the delivery of respiratory...
US20110182997 SUSPENSION FORMULATIONS  
The present invention relates to suspension formulations, especially those for delivering a pharmaceutically active agent in aerosol form using a spray or aerosol device, such as a pressurised...
US20110146678 PROCESS FOR IMPROVING CRYSTALLINITY  
This invention provides a process for increasing the crystallinity of at least one solid material which is less than 100% crystalline, comprising contacting said solid material with solvent in...

Matches 251 - 297 out of 297 < 1 2 3 4 5 6